Hohenester, S.* ; Kanitz, V.* ; Schiergens, T.* ; Einer, C. ; Nagel, J.* ; Wimmer, R.* ; Reiter, F.P.* ; Gerbes, A.L.* ; de Toni, E.N.* ; Bauer, C.* ; Holdt, L.* ; Mayr, D.* ; Rust, C.* ; Schnurr, M.* ; Zischka, H. ; Geier, A.* ; Denk, G.*
     
    
        
IL-18 but not IL-1 signaling is pivotal for the initiation of liver injury in murine non-alcoholic fatty liver disease.
    
    
        
    
    
        
        Int. J. Mol. Sci. 21:8602 (2020)
    
    
    
      
      
	
	    Non-alcoholic fatty liver disease (NAFLD) is rising in prevalence, and a better pathophysiologic understanding of the transition to its inflammatory phenotype (NASH) is key to the development of effective therapies. To evaluate the contribution of the NLRP3 inflammasome and its downstream effectors IL-1 and IL-18 in this process, we applied the true-to-life “American lifestyle-induced obesity syndrome” (ALiOS) diet mouse model. Development of obesity, fatty liver and liver damage was investigated in mice fed for 24 weeks according to the ALiOS protocol. Lipidomic changes in mouse livers were compared to human NAFLD samples. Receptor knockout mice for IL-1 and IL-18 were used to dissect the impact of downstream signals of inflammasome activity on the development of NAFLD. The ALiOS diet induced obesity and liver steatosis. The lipidomic changes closely mimicked changes in human NAFLD. A pro-inflammatory gene expression pattern in liver tissue and increased serum liver transaminases indicated early liver damage in the absence of histological evidence of NASH. Mechanistically, Il-18r−/−-but not Il-1r−/− mice were protected from early liver damage, possibly due to silencing of the pro-inflammatory gene expression pattern. Our study identified NLRP3 activation and IL-18R-dependent signaling as potential modulators of early liver damage in NAFLD, preceding development of histologic NASH.
	
	
	    
	
       
      
	
	    
		Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Scopus
Cited By
		Altmetric
		
	     
	    
	 
       
      
     
    
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
    
        Thesis type
        
    
 
    
        Editors
        
    
    
        Keywords
        Alios ; Inflammasome ; Interleukin 1 ; Interleukin 18 ; Nafld ; Nash ; Nlrp3 ; Western Diet; Acid Compositions; Scoring System; Tissue; Nafld; Steatohepatitis; Inflammasomes; Mitochondria; Progression; Steatosis; Fructose
    
 
    
        Keywords plus
        
    
 
    
    
        Language
        english
    
 
    
        Publication Year
        2020
    
 
    
        Prepublished in Year
        
    
 
    
        HGF-reported in Year
        2020
    
 
    
    
        ISSN (print) / ISBN
        1661-6596
    
 
    
        e-ISSN
        1422-0067
    
 
    
        ISBN
        
    
    
        Book Volume Title
        
    
 
    
        Conference Title
        
    
 
	
        Conference Date
        
    
     
	
        Conference Location
        
    
 
	
        Proceedings Title
        
    
 
     
	
    
        Quellenangaben
        
	    Volume: 21,  
	    Issue: 22,  
	    Pages: ,  
	    Article Number: 8602 
	    Supplement: ,  
	
    
 
    
        
            Series
            
        
 
        
            Publisher
            MDPI
        
 
        
            Publishing Place
            Basel
        
 
	
        
            Day of Oral Examination
            0000-00-00
        
 
        
            Advisor
            
        
 
        
            Referee
            
        
 
        
            Examiner
            
        
 
        
            Topic
            
        
 
	
        
            University
            
        
 
        
            University place
            
        
 
        
            Faculty
            
        
 
    
        
            Publication date
            0000-00-00
        
 
         
        
            Application date
            0000-00-00
        
 
        
            Patent owner
            
        
 
        
            Further owners
            
        
 
        
            Application country
            
        
 
        
            Patent priority
            
        
 
    
        Reviewing status
        Peer reviewed
    
 
     
    
        POF-Topic(s)
        30203 - Molecular Targets and Therapies
    
 
    
        Research field(s)
        Enabling and Novel Technologies
    
 
    
        PSP Element(s)
        G-505200-003
    
 
    
        Grants
        Eli Lilly and Company
Berlin Mathematical School
Faculty of Medicine, Munich University of Technology
Ludwig-Maximilians-Universitat Munchen
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2020-12-01